TOKYO--(BUSINESS WIRE)--Nov 1, 2023--NIPPON KINZOKU CO., LTD. (TOKYO: 5491) (Headquarters: Minato-ku, Tokyo) commercialized 鈥淣K-304LCO鈥� stainless steel for injection needles in November 2020, which is compliant with the Cobalt composition regulation of the European Medical Devices ...
LONDON & NEW YORK--(BUSINESS WIRE)--Nov 1, 2023--ViroCell Biologics (鈥淰iroCell鈥� or the 鈥淐ompany鈥�), a specialist contract development and manufacturing organisation (鈥淐DMO鈥�) for cell and gene therapy (CGT) clinical trials, announces that the Company is now able to ...
<p style="TEXT-ALIGN:CENTER">- Data demonstrate feasibility, tolerability, and early efficacy of mRNA/LNP in vivo CAR-M therapy in pre-clinical models of metastatic solid tumors<p style="TEXT-ALIGN:CENTER">- Proof of concept achieved for platform under the Moderna ...
DUBLIN--(BUSINESS WIRE)--Oct 31, 2023--The <a ...
SAN FRANCISCO--(BUSINESS WIRE)--Oct 31, 2023--<a ...
NEEDHAM, Mass.--(BUSINESS WIRE)--Oct 31, 2023--International Data Corporation ( <a ...
